CD38 and Duchenne muscular dystrophy: In various dystrophic mouse models and a human DMD cell culture, we have targeted the multifunctional enzyme CD38, a NAD+ glycohydrolase that generates Ca2+ signaling modulators from NAD+, by genetic or pharmacological inhibition.